The global Natural Killer Cell Therapeutics market was valued at US$ 135 million in 2023 and is anticipated to reach US$ 1362 million by 2030, witnessing a CAGR of 39.1% during the forecast period 2024-2030.

Natural Killer Cell Therapeutics Market

NK cells, a type of immune cell, have received a lot of attention for their natural capacity to recognize and kill malignant cells. Advances in understanding NK cell biology and its interactions with Cancer have resulted in the development of new medicines that harness the potential of these cells. With the success of CAR-NK cell therapies in preclinical and early clinical trials, there is growing optimism about the ability of NK cell-based immunotherapies to treat a wide spectrum of cancer types.

Another important driver for the NK Cell Therapeutics Market is the rising global prevalence of Cancer, combined with ongoing unmet medical needs in cancer treatment. Despite advances in traditional medicines such as chemotherapy and targeted therapy, certain malignancies continue to be refractory or develop treatment resistance. This highlights the critical need for novel therapeutic approaches, such as NK cell-based immunotherapy, which has the potential to improve efficacy while reducing adverse effects. As the cancer burden grows, fuelled by factors such as aging populations and lifestyle changes, there is an increasing need to discover effective medicines, driving demand for NK cell therapeutics.

This report aims to provide a comprehensive presentation of the global market for Natural Killer Cell Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Natural Killer Cell Therapeutics.

The Natural Killer Cell Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Natural Killer Cell Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Natural Killer Cell Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Natural Killer Cell Therapeutics Market Report

Report Metric	Details
Report Name	Natural Killer Cell Therapeutics Market
Accounted market size in 2023	US$ 135 million
Forecasted market size in 2030	US$ 1362 million
CAGR	39.1%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	NK Cell Therapies NK Cell Directed Antibodies
Segment by Application	Research & Academic Institutes Hospitals Specialty Clinics
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Merck KGaA, Bristol-Myers Squibb Company, Glycostem, Sanofi, Cytovia Therapeutics, ImmunityBio, Inc., Biohaven Pharmaceuticals, Fate Therapeutics, EMERcell, Phio Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Natural Killer Cell Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Natural Killer Cell Therapeutics Market growing?

Ans: The Natural Killer Cell Therapeutics Market witnessing a CAGR of 39.1% during the forecast period 2024-2030.

What is the Natural Killer Cell Therapeutics Market size in 2030?

Ans: The Natural Killer Cell Therapeutics Market size in 2030 will be US$ 1362 million.

Who are the main players in the Natural Killer Cell Therapeutics Market report?

Ans: The main players in the Natural Killer Cell Therapeutics Market are Merck KGaA, Bristol-Myers Squibb Company, Glycostem, Sanofi, Cytovia Therapeutics, ImmunityBio, Inc., Biohaven Pharmaceuticals, Fate Therapeutics, EMERcell, Phio Pharmaceuticals

What are the Application segmentation covered in the Natural Killer Cell Therapeutics Market report?

Ans: The Applications covered in the Natural Killer Cell Therapeutics Market report are Research & Academic Institutes, Hospitals, Specialty Clinics

What are the Type segmentation covered in the Natural Killer Cell Therapeutics Market report?

Ans: The Types covered in the Natural Killer Cell Therapeutics Market report are NK Cell Therapies, NK Cell Directed Antibodies

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Natural Killer Cell Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 NK Cell Therapies

1.2.3 NK Cell Directed Antibodies

1.3 Market by Application

1.3.1 Global Natural Killer Cell Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Research & Academic Institutes

1.3.3 Hospitals

1.3.4 Specialty Clinics

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Natural Killer Cell Therapeutics Market Perspective (2019-2030)

2.2 Global Natural Killer Cell Therapeutics Growth Trends by Region

2.2.1 Global Natural Killer Cell Therapeutics Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Natural Killer Cell Therapeutics Historic Market Size by Region (2019-2024)

2.2.3 Natural Killer Cell Therapeutics Forecasted Market Size by Region (2025-2030)

2.3 Natural Killer Cell Therapeutics Market Dynamics

2.3.1 Natural Killer Cell Therapeutics Industry Trends

2.3.2 Natural Killer Cell Therapeutics Market Drivers

2.3.3 Natural Killer Cell Therapeutics Market Challenges

2.3.4 Natural Killer Cell Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Natural Killer Cell Therapeutics Players by Revenue

3.1.1 Global Top Natural Killer Cell Therapeutics Players by Revenue (2019-2024)

3.1.2 Global Natural Killer Cell Therapeutics Revenue Market Share by Players (2019-2024)

3.2 Global Natural Killer Cell Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Natural Killer Cell Therapeutics Revenue

3.4 Global Natural Killer Cell Therapeutics Market Concentration Ratio

3.4.1 Global Natural Killer Cell Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Natural Killer Cell Therapeutics Revenue in 2023

3.5 Global Key Players of Natural Killer Cell Therapeutics Head office and Area Served

3.6 Global Key Players of Natural Killer Cell Therapeutics, Product and Application

3.7 Global Key Players of Natural Killer Cell Therapeutics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Natural Killer Cell Therapeutics Breakdown Data by Type

4.1 Global Natural Killer Cell Therapeutics Historic Market Size by Type (2019-2024)

4.2 Global Natural Killer Cell Therapeutics Forecasted Market Size by Type (2025-2030)

5 Natural Killer Cell Therapeutics Breakdown Data by Application

5.1 Global Natural Killer Cell Therapeutics Historic Market Size by Application (2019-2024)

5.2 Global Natural Killer Cell Therapeutics Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Natural Killer Cell Therapeutics Market Size (2019-2030)

6.2 North America Natural Killer Cell Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Natural Killer Cell Therapeutics Market Size by Country (2019-2024)

6.4 North America Natural Killer Cell Therapeutics Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Natural Killer Cell Therapeutics Market Size (2019-2030)

7.2 Europe Natural Killer Cell Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Natural Killer Cell Therapeutics Market Size by Country (2019-2024)

7.4 Europe Natural Killer Cell Therapeutics Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Natural Killer Cell Therapeutics Market Size (2019-2030)

8.2 Asia-Pacific Natural Killer Cell Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Natural Killer Cell Therapeutics Market Size by Region (2019-2024)

8.4 Asia-Pacific Natural Killer Cell Therapeutics Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Natural Killer Cell Therapeutics Market Size (2019-2030)

9.2 Latin America Natural Killer Cell Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Natural Killer Cell Therapeutics Market Size by Country (2019-2024)

9.4 Latin America Natural Killer Cell Therapeutics Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Natural Killer Cell Therapeutics Market Size (2019-2030)

10.2 Middle East & Africa Natural Killer Cell Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Natural Killer Cell Therapeutics Market Size by Country (2019-2024)

10.4 Middle East & Africa Natural Killer Cell Therapeutics Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Merck KGaA

11.1.1 Merck KGaA Company Details

11.1.2 Merck KGaA Business Overview

11.1.3 Merck KGaA Natural Killer Cell Therapeutics Introduction

11.1.4 Merck KGaA Revenue in Natural Killer Cell Therapeutics Business (2019-2024)

11.1.5 Merck KGaA Recent Development

11.2 Bristol-Myers Squibb Company

11.2.1 Bristol-Myers Squibb Company Company Details

11.2.2 Bristol-Myers Squibb Company Business Overview

11.2.3 Bristol-Myers Squibb Company Natural Killer Cell Therapeutics Introduction

11.2.4 Bristol-Myers Squibb Company Revenue in Natural Killer Cell Therapeutics Business (2019-2024)

11.2.5 Bristol-Myers Squibb Company Recent Development

11.3 Glycostem

11.3.1 Glycostem Company Details

11.3.2 Glycostem Business Overview

11.3.3 Glycostem Natural Killer Cell Therapeutics Introduction

11.3.4 Glycostem Revenue in Natural Killer Cell Therapeutics Business (2019-2024)

11.3.5 Glycostem Recent Development

11.4 Sanofi

11.4.1 Sanofi Company Details

11.4.2 Sanofi Business Overview

11.4.3 Sanofi Natural Killer Cell Therapeutics Introduction

11.4.4 Sanofi Revenue in Natural Killer Cell Therapeutics Business (2019-2024)

11.4.5 Sanofi Recent Development

11.5 Cytovia Therapeutics

11.5.1 Cytovia Therapeutics Company Details

11.5.2 Cytovia Therapeutics Business Overview

11.5.3 Cytovia Therapeutics Natural Killer Cell Therapeutics Introduction

11.5.4 Cytovia Therapeutics Revenue in Natural Killer Cell Therapeutics Business (2019-2024)

11.5.5 Cytovia Therapeutics Recent Development

11.6 ImmunityBio, Inc.

11.6.1 ImmunityBio, Inc. Company Details

11.6.2 ImmunityBio, Inc. Business Overview

11.6.3 ImmunityBio, Inc. Natural Killer Cell Therapeutics Introduction

11.6.4 ImmunityBio, Inc. Revenue in Natural Killer Cell Therapeutics Business (2019-2024)

11.6.5 ImmunityBio, Inc. Recent Development

11.7 Biohaven Pharmaceuticals

11.7.1 Biohaven Pharmaceuticals Company Details

11.7.2 Biohaven Pharmaceuticals Business Overview

11.7.3 Biohaven Pharmaceuticals Natural Killer Cell Therapeutics Introduction

11.7.4 Biohaven Pharmaceuticals Revenue in Natural Killer Cell Therapeutics Business (2019-2024)

11.7.5 Biohaven Pharmaceuticals Recent Development

11.8 Fate Therapeutics

11.8.1 Fate Therapeutics Company Details

11.8.2 Fate Therapeutics Business Overview

11.8.3 Fate Therapeutics Natural Killer Cell Therapeutics Introduction

11.8.4 Fate Therapeutics Revenue in Natural Killer Cell Therapeutics Business (2019-2024)

11.8.5 Fate Therapeutics Recent Development

11.9 EMERcell

11.9.1 EMERcell Company Details

11.9.2 EMERcell Business Overview

11.9.3 EMERcell Natural Killer Cell Therapeutics Introduction

11.9.4 EMERcell Revenue in Natural Killer Cell Therapeutics Business (2019-2024)

11.9.5 EMERcell Recent Development

11.10 Phio Pharmaceuticals

11.10.1 Phio Pharmaceuticals Company Details

11.10.2 Phio Pharmaceuticals Business Overview

11.10.3 Phio Pharmaceuticals Natural Killer Cell Therapeutics Introduction

11.10.4 Phio Pharmaceuticals Revenue in Natural Killer Cell Therapeutics Business (2019-2024)

11.10.5 Phio Pharmaceuticals Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Merck KGaA

Bristol Myers Squibb Company

Biohaven Pharmaceuticals

EMERcell

List of Tables

Table 1. Global Natural Killer Cell Therapeutics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of NK Cell Therapies

Table 3. Key Players of NK Cell Directed Antibodies

Table 4. Global Natural Killer Cell Therapeutics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global Natural Killer Cell Therapeutics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Natural Killer Cell Therapeutics Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Natural Killer Cell Therapeutics Market Share by Region (2019-2024)

Table 8. Global Natural Killer Cell Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Natural Killer Cell Therapeutics Market Share by Region (2025-2030)

Table 10. Natural Killer Cell Therapeutics Market Trends

Table 11. Natural Killer Cell Therapeutics Market Drivers

Table 12. Natural Killer Cell Therapeutics Market Challenges

Table 13. Natural Killer Cell Therapeutics Market Restraints

Table 14. Global Natural Killer Cell Therapeutics Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Natural Killer Cell Therapeutics Market Share by Players (2019-2024)

Table 16. Global Top Natural Killer Cell Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Natural Killer Cell Therapeutics as of 2023)

Table 17. Ranking of Global Top Natural Killer Cell Therapeutics Companies by Revenue (US$ Million) in 2023

Table 18. Global 5 Largest Players Market Share by Natural Killer Cell Therapeutics Revenue (CR5 and HHI) & (2019-2024)

Table 19. Global Key Players of Natural Killer Cell Therapeutics, Headquarters and Area Served

Table 20. Global Key Players of Natural Killer Cell Therapeutics, Product and Application

Table 21. Global Key Players of Natural Killer Cell Therapeutics, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Natural Killer Cell Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Natural Killer Cell Therapeutics Revenue Market Share by Type (2019-2024)

Table 25. Global Natural Killer Cell Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Natural Killer Cell Therapeutics Revenue Market Share by Type (2025-2030)

Table 27. Global Natural Killer Cell Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Natural Killer Cell Therapeutics Revenue Market Share by Application (2019-2024)

Table 29. Global Natural Killer Cell Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Natural Killer Cell Therapeutics Revenue Market Share by Application (2025-2030)

Table 31. North America Natural Killer Cell Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 32. North America Natural Killer Cell Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 33. North America Natural Killer Cell Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 34. Europe Natural Killer Cell Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. Europe Natural Killer Cell Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 36. Europe Natural Killer Cell Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 37. Asia-Pacific Natural Killer Cell Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. Asia-Pacific Natural Killer Cell Therapeutics Market Size by Region (2019-2024) & (US$ Million)

Table 39. Asia-Pacific Natural Killer Cell Therapeutics Market Size by Region (2025-2030) & (US$ Million)

Table 40. Latin America Natural Killer Cell Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Latin America Natural Killer Cell Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 42. Latin America Natural Killer Cell Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 43. Middle East & Africa Natural Killer Cell Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Middle East & Africa Natural Killer Cell Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 45. Middle East & Africa Natural Killer Cell Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 46. Merck KGaA Company Details

Table 47. Merck KGaA Business Overview

Table 48. Merck KGaA Natural Killer Cell Therapeutics Product

Table 49. Merck KGaA Revenue in Natural Killer Cell Therapeutics Business (2019-2024) & (US$ Million)

Table 50. Merck KGaA Recent Development

Table 51. Bristol-Myers Squibb Company Company Details

Table 52. Bristol-Myers Squibb Company Business Overview

Table 53. Bristol-Myers Squibb Company Natural Killer Cell Therapeutics Product

Table 54. Bristol-Myers Squibb Company Revenue in Natural Killer Cell Therapeutics Business (2019-2024) & (US$ Million)

Table 55. Bristol-Myers Squibb Company Recent Development

Table 56. Glycostem Company Details

Table 57. Glycostem Business Overview

Table 58. Glycostem Natural Killer Cell Therapeutics Product

Table 59. Glycostem Revenue in Natural Killer Cell Therapeutics Business (2019-2024) & (US$ Million)

Table 60. Glycostem Recent Development

Table 61. Sanofi Company Details

Table 62. Sanofi Business Overview

Table 63. Sanofi Natural Killer Cell Therapeutics Product

Table 64. Sanofi Revenue in Natural Killer Cell Therapeutics Business (2019-2024) & (US$ Million)

Table 65. Sanofi Recent Development

Table 66. Cytovia Therapeutics Company Details

Table 67. Cytovia Therapeutics Business Overview

Table 68. Cytovia Therapeutics Natural Killer Cell Therapeutics Product

Table 69. Cytovia Therapeutics Revenue in Natural Killer Cell Therapeutics Business (2019-2024) & (US$ Million)

Table 70. Cytovia Therapeutics Recent Development

Table 71. ImmunityBio, Inc. Company Details

Table 72. ImmunityBio, Inc. Business Overview

Table 73. ImmunityBio, Inc. Natural Killer Cell Therapeutics Product

Table 74. ImmunityBio, Inc. Revenue in Natural Killer Cell Therapeutics Business (2019-2024) & (US$ Million)

Table 75. ImmunityBio, Inc. Recent Development

Table 76. Biohaven Pharmaceuticals Company Details

Table 77. Biohaven Pharmaceuticals Business Overview

Table 78. Biohaven Pharmaceuticals Natural Killer Cell Therapeutics Product

Table 79. Biohaven Pharmaceuticals Revenue in Natural Killer Cell Therapeutics Business (2019-2024) & (US$ Million)

Table 80. Biohaven Pharmaceuticals Recent Development

Table 81. Fate Therapeutics Company Details

Table 82. Fate Therapeutics Business Overview

Table 83. Fate Therapeutics Natural Killer Cell Therapeutics Product

Table 84. Fate Therapeutics Revenue in Natural Killer Cell Therapeutics Business (2019-2024) & (US$ Million)

Table 85. Fate Therapeutics Recent Development

Table 86. EMERcell Company Details

Table 87. EMERcell Business Overview

Table 88. EMERcell Natural Killer Cell Therapeutics Product

Table 89. EMERcell Revenue in Natural Killer Cell Therapeutics Business (2019-2024) & (US$ Million)

Table 90. EMERcell Recent Development

Table 91. Phio Pharmaceuticals Company Details

Table 92. Phio Pharmaceuticals Business Overview

Table 93. Phio Pharmaceuticals Natural Killer Cell Therapeutics Product

Table 94. Phio Pharmaceuticals Revenue in Natural Killer Cell Therapeutics Business (2019-2024) & (US$ Million)

Table 95. Phio Pharmaceuticals Recent Development

Table 96. Research Programs/Design for This Report

Table 97. Key Data Information from Secondary Sources

Table 98. Key Data Information from Primary Sources

Table 99. Authors List of This Report

List of Figures

Figure 1. Natural Killer Cell Therapeutics Picture

Figure 2. Global Natural Killer Cell Therapeutics Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Natural Killer Cell Therapeutics Market Share by Type: 2023 VS 2030

Figure 4. NK Cell Therapies Features

Figure 5. NK Cell Directed Antibodies Features

Figure 6. Global Natural Killer Cell Therapeutics Market Size by Application (2024-2030) & (US$ Million)

Figure 7. Global Natural Killer Cell Therapeutics Market Share by Application: 2023 VS 2030

Figure 8. Research & Academic Institutes Case Studies

Figure 9. Hospitals Case Studies

Figure 10. Specialty Clinics Case Studies

Figure 11. Natural Killer Cell Therapeutics Report Years Considered

Figure 12. Global Natural Killer Cell Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 13. Global Natural Killer Cell Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Natural Killer Cell Therapeutics Market Share by Region: 2023 VS 2030

Figure 15. Global Natural Killer Cell Therapeutics Market Share by Players in 2023

Figure 16. Global Top Natural Killer Cell Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Natural Killer Cell Therapeutics as of 2023)

Figure 17. The Top 10 and 5 Players Market Share by Natural Killer Cell Therapeutics Revenue in 2023

Figure 18. North America Natural Killer Cell Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. North America Natural Killer Cell Therapeutics Market Share by Country (2019-2030)

Figure 20. United States Natural Killer Cell Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Canada Natural Killer Cell Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe Natural Killer Cell Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Natural Killer Cell Therapeutics Market Share by Country (2019-2030)

Figure 24. Germany Natural Killer Cell Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. France Natural Killer Cell Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. U.K. Natural Killer Cell Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Italy Natural Killer Cell Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Russia Natural Killer Cell Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Nordic Countries Natural Killer Cell Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific Natural Killer Cell Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Natural Killer Cell Therapeutics Market Share by Region (2019-2030)

Figure 32. China Natural Killer Cell Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Japan Natural Killer Cell Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. South Korea Natural Killer Cell Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Southeast Asia Natural Killer Cell Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. India Natural Killer Cell Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Australia Natural Killer Cell Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America Natural Killer Cell Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Natural Killer Cell Therapeutics Market Share by Country (2019-2030)

Figure 40. Mexico Natural Killer Cell Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Brazil Natural Killer Cell Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa Natural Killer Cell Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Natural Killer Cell Therapeutics Market Share by Country (2019-2030)

Figure 44. Turkey Natural Killer Cell Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Saudi Arabia Natural Killer Cell Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. UAE Natural Killer Cell Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Merck KGaA Revenue Growth Rate in Natural Killer Cell Therapeutics Business (2019-2024)

Figure 48. Bristol-Myers Squibb Company Revenue Growth Rate in Natural Killer Cell Therapeutics Business (2019-2024)

Figure 49. Glycostem Revenue Growth Rate in Natural Killer Cell Therapeutics Business (2019-2024)

Figure 50. Sanofi Revenue Growth Rate in Natural Killer Cell Therapeutics Business (2019-2024)

Figure 51. Cytovia Therapeutics Revenue Growth Rate in Natural Killer Cell Therapeutics Business (2019-2024)

Figure 52. ImmunityBio, Inc. Revenue Growth Rate in Natural Killer Cell Therapeutics Business (2019-2024)

Figure 53. Biohaven Pharmaceuticals Revenue Growth Rate in Natural Killer Cell Therapeutics Business (2019-2024)

Figure 54. Fate Therapeutics Revenue Growth Rate in Natural Killer Cell Therapeutics Business (2019-2024)

Figure 55. EMERcell Revenue Growth Rate in Natural Killer Cell Therapeutics Business (2019-2024)

Figure 56. Phio Pharmaceuticals Revenue Growth Rate in Natural Killer Cell Therapeutics Business (2019-2024)

Figure 57. Bottom-up and Top-down Approaches for This Report

Figure 58. Data Triangulation

Figure 59. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions